KBC Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Buy |
60,337
+932
| +2% | +$33.6K | 0.01% | 569 |
|
|
2025
Q1 | $1.85M | Buy |
59,405
+17,851
| +43% | +$556K | 0.01% | 603 |
|
|
2024
Q4 | $1.06M | Hold |
41,554
| – | – | ﹤0.01% | 756 |
|
|
2024
Q3 | $1.18M | Buy |
41,554
+16,081
| +63% | +$455K | ﹤0.01% | 669 |
|
|
2024
Q2 | $672K | Hold |
25,473
| – | – | ﹤0.01% | 700 |
|
|
2024
Q1 | $773K | Sell |
25,473
-4,553
| -15% | -$138K | ﹤0.01% | 693 |
|
|
2023
Q4 | $844K | Buy |
30,026
+370
| +1% | +$10.4K | ﹤0.01% | 702 |
|
|
2023
Q3 | $804K | Sell |
29,656
-59,800
| -67% | -$1.62M | ﹤0.01% | 703 |
|
|
2023
Q2 | $2.75M | Sell |
89,456
-6,313
| -7% | -$194K | 0.01% | 556 |
|
|
2023
Q1 | $3.45M | Buy |
95,769
+64,048
| +202% | +$2.31M | 0.01% | 560 |
|
|
2022
Q4 | $1.25M | Buy |
31,721
+24
| +0.1% | +$948 | 0.01% | 673 |
|
|
2022
Q3 | $1.27M | Buy |
31,697
+271
| +0.9% | +$10.9K | 0.01% | 630 |
|
|
2022
Q2 | $1.32M | Sell |
31,426
-14,766
| -32% | -$621K | 0.01% | 622 |
|
|
2022
Q1 | $1.8M | Buy |
46,192
+14,841
| +47% | +$578K | 0.01% | 603 |
|
|
2021
Q4 | $1.25M | Buy |
31,351
+2,493
| +9% | +$99.3K | ﹤0.01% | 688 |
|
|
2021
Q3 | $1.04M | Sell |
28,858
-31,400
| -52% | -$1.13M | ﹤0.01% | 750 |
|
|
2021
Q2 | $2.47M | Sell |
60,258
-2,946
| -5% | -$121K | ﹤0.01% | 737 |
|
|
2021
Q1 | $2.76M | Sell |
63,204
-103,562
| -62% | -$4.52M | 0.01% | 699 |
|
|
2020
Q4 | $45.9M | Buy |
+166,766
| New | +$45.9M | 0.02% | 499 |
|